(Q24650472)

7

1 reference

ORCID Public Data File 2021

author name string

David T Teachey

1

0 references

Robert Greiner

2

0 references

Alix Seif

3

0 references

Edward Attiyeh

4

0 references

Jack Bleesing

5

0 references

John Choi

6

0 references

Eric Rappaport

8

0 references

Dirk Schwabe

9

0 references

Cecilia Sheen

10

0 references

Kathleen E Sullivan

11

0 references

Hongming Zhuang

12

0 references

Daniel S Wechsler

British Journal of Haematology

13

0 references

language of work or name

English

0 references

publication date

April 2009

0 references

published in

0 references

volume

145

0 references

issue

1

0 references

page(s)

101-6

0 references

cites work

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Mammalian target of rapamycin as a target in hematological malignancies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Human regulatory T cells: role in autoimmune disease and therapeutic opportunities

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Spotlight on autoimmune lymphoproliferative syndrome.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients

28 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2009.07595.X

Targeting Notch signaling in autoimmune and lymphoproliferative disease

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819393

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19208097